Isolation and Characterization of Bifidobacterium longum subsp. longum BCBR-583 for Probiotic Applications in Fermented Foods
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Recent human gut microbiome studies have supported that the genus Bifidobacterium is one of the most beneficial bacteria for human intestinal health. To develop a new probiotic strain for functional food applications, fourteen fecal samples were collected from healthy Koreans and the strain BCBR-583 was newly selected and isolated from a 25-year-old Korean woman’s fecal sample using the selective medium for Bifidobacterium. Subsequent fructose-6-phosphate phosphoketolase (F6PPK) test and 16S rRNA gene sequencing analysis of the strain BCBR-583 confirmed that it belongs to B. longum subsp. longum. The stress resistance tests showed that it has oxygen and heat tolerance activities (5- and 3.9-fold increase for 24 h at 60 and 120 rpm, respectively; 78.61 ± 6.67% survival rate at 45°C for 24 h). In addition, gut environment adaptation tests revealed that this strain may be well-adapted in the gut habitat, with gastric acid/bile salt resistance (85.79 ± 1.53%, survival rate under 6 h treatments of gastric acid and bile salt) and mucin adhesion (73.72 ± 7.36%). Furthermore, additional tests including cholesterol lowering assay showed that it can reduce 86.31 ± 1.85% of cholesterol. Based on these results, B. longum BCBR-583 has various stress resistance for survival during food processing and environmental adaptation activities for dominant survival in the gut, suggesting that it could be a good candidate for fermented food applications as a new probiotic strain.
Abstract
Recent human gut microbiome studies have supported that the genus Bifidobacterium is one of the most beneficial bacteria for human intestinal health. To develop a new probiotic strain for functional food applications, fourteen fecal samples were collected from healthy Koreans and the strain BCBR-583 was newly selected and isolated from a 25-year-old Korean woman’s fecal sample using the selective medium for Bifidobacterium. Subsequent fructose-6-phosphate phosphoketolase (F6PPK) test and 16S rRNA gene sequencing analysis of the strain BCBR-583 confirmed that it belongs to B. longum subsp. longum. The stress resistance tests showed that it has oxygen and heat tolerance activities (5- and 3.9-fold increase for 24 h at 60 and 120 rpm, respectively; 78.61 ± 6.67% survival rate at 45°C for 24 h). In addition, gut environment adaptation tests revealed that this strain may be well-adapted in the gut habitat, with gastric acid/bile salt resistance (85.79 ± 1.53%, survival rate under 6 h treatments of gastric acid and bile salt) and mucin adhesion (73.72 ± 7.36%). Furthermore, additional tests including cholesterol lowering assay showed that it can reduce 86.31 ± 1.85% of cholesterol. Based on these results, B. longum BCBR-583 has various stress resistance for survival during food processing and environmental adaptation activities for dominant survival in the gut, suggesting that it could be a good candidate for fermented food applications as a new probiotic strain.
참고문헌 (21)
- Tissier H., "Le bacterium coli et la reaction chromophile d’escherich", Crit. Rev. Soc. Biol, 51, pp.943~945 (1899)
- O'Callaghan A, "Bifidobacteria and their role as members of the human gut microbiota", Front Microbiol, 7, pp.925~ (2016)
- Lee J-H, "Genomic insights into bifidobacteria", Microbiol. Mol. Biol. Rev, 74, pp.378~416 (2010)
- Tissier H., "Traitement des infections intestinales par la méthode de transformation de la flore bactérienne de l'intestin", Compt. Rend Soc. Biol, 60, pp.359~361 (1906)
- Li Y, "Effects of Bifidobacterium breve supplementation on intestinal flora of low birth weight infants", Pediatr. Int, 46, pp.509~515 (2004)
- Agrawal A, "Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation", Aliment Pharmacol. Ther, 29, pp.104~114 (2009)
- Jiang T, "Improvement of lactose digestion in humans by ingestion of unfermented milk containing Bifidobacterium longum", J. Dairy Sci, 79, pp.750~757 (1996)
- Ataie-Jafari A, "Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects", Ann. Nutr. Metab, 54, pp.22~27 (2009)
- Kim N, "Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4+CD45RBhigh T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation", Clin. Immunol, 123, pp.30~39 (2007)
- Sekine K, "A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice", Cancer Res, 45, pp.1300~1307 (1985)
- Ishibashi N, "Bifidobacteria:their significance in human intestinal health", Mal. J. Nutr, 3, pp.149~159 (1997)
- Lee J-H, "Comparative genomic analysis of the gut bacterium Bifidobacterium longum reveals loci susceptible to deletion during pure culture growth", BMC Genomics, 9, pp.247~ (2008)
- Munoa F, "Selective medium for isolation and enumeration of Bifidobacterium spp", Appl. Environ. Microbiol, 54, pp.1715~1718 (1988)
- Gavini F, "Detection of fructose-6-phosphate phosphoketolase (F6PPK), a key enzyme of the bifid-shunt, in Gardnerella vaginalis", Anaerobe, 3, pp.191~193 (1996)
- Altschul SF, "Basic local alignment search tool", J. Mol. Biol, 215, pp.403~410 (1990)
- Grasso EM, "Minimal effects of high-pressure treatment on Salmonella enterica serovar Typhimurium inoculated into peanut butter and peanut products", J. Food Sci, 75, pp.E522~E526 (2010)
- Azcarate-Peril M, "Temporal gene expression and probiotic attributes of Lactobacillus acidophilus during growth in milk", J. Dairy Sci, 92, pp.870~886 (2009)
- Grimoud J, "In vitro screening of probiotic lactic acid bacteria and prebiotic glucooligosaccharides to select effective synbiotics", Anaerobe, 16, pp.493~500 (2010)
- Ruas-Madiedo P, "Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics and enteropathogens to human intestinal mucus", J. Food Prot, 69, pp.2011~2015 (2006)
- Dambekodi P, "Incorporation of cholesterol into the cellular membrane of Bifidobacterium longum", J. Dairy Sci, 81, pp.1818~1824 (1998)
- Sgouras D, "In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota", Appl. Environ. Microbiol, 70, pp.518~526 (2004)